Back

Explore every episode of the podcast Healthcare Logic for Growth

Dive into the complete episode list for Healthcare Logic for Growth. Each episode is cataloged with detailed descriptions, making it easy to find and explore specific topics. Keep track of all episodes from your favorite podcast and never miss a moment of insightful content.

Rows per page:

1–23 of 23

TitlePub. DateDuration
Prevention Gets a Scoreboard: Chronic Disease, Behavioral Health & Community-Based Care in Rural Texas28 sept. 202600:24:11

Texas put its first Rural Texas Strong dollars into Make Rural Texans Healthy Again - and buried in the fine print is a pay-for-performance structure that reserves most outcome-based payments for Years 4 and 5. In this episode, Eric Marr unpacks what that means for rural hospital districts, hospitals, clinics, FQHCs, and behavioral health providers; why behavioral health is threaded through the program rather than funded as a standalone bucket; and why community-based care - CHWs, transportation, food access, and remote monitoring - is where outcomes actually move. Plus: three common misconceptions, a real-world board-room scenario, five takeaways, and a Go Forward Strategy for providers and the companies that serve them.

In This Episode

  1. Why chronic disease and prevention were first out the door in Rural Texas Strong
  2. Make Rural Texans Healthy Again: Part 1 direct awards vs. Part 2 competitive awards
  3. The pay-for-performance structure — and why Year 1 decisions drive Year 4 dollars
  4. Behavioral health as a thread across initiatives, and the Texas psychiatric workforce gap
  5. Community-based care: CHWs, transportation, food-access infrastructure, and remote monitoring
  6. Three misconceptions about prevention funding
  7. Listener scenario: the wellness center vs. the registry
  8. Five takeaways and a Go Forward Strategy by audience

Who Should Listen

Rural hospital district leaders, CAH and rural hospital executives, RHC and FQHC leaders, behavioral health and substance use providers, EMS directors, and life science, medtech, and digital health companies serving rural Texas.

Sources Used to Generate This Episode

  1. Texas HHSC Provider Finance - Rural Health Transformation Program (Rural Texas Strong) main page
  2. HHSC - Rural Texas Strong: Supporting Health and Wellness (Fact Sheet)
  3. HHSC - Approved Budget Period 1 Revised Project Narrative (CMS-approved Apr. 7, 2026)
  4. HHSC - Approved Budget Period 1 Revised Budget Narrative
  5. Texas DSHS Public Health Funding & Policy Committee - RHTP Update (Feb. 11, 2026)
  6. HHSC Medical Care Advisory Committee - RHTP Update (Feb. 12, 2026)
  7. Office of the Texas Governor - $60 Million to 'Make Rural Texans Healthy Again' (Apr. 23, 2026)
  8. Office of the Texas Governor - $1.4 Billion Secured for Rural Texas Strong (Dec. 29, 2025)
  9. REDi Health - Texas Rural Health Transformation Program Update (Jul. 31, 2026)
  10. TXInsight - HHS Rural Health Transformation budget detail (Apr. 2026)
  11. Texans Care for Children - Texas' Big Rural Health Moment (Dec. 2025)
  12. Episcopal Health Foundation - Transforming Rural Health in Texas (Dec. 2025)
  13. The Texas Tribune -Texas behavioral health workforce explainer (DSHS data)

 

If you'd like help with your RHTP strategy...shoot me an email: eric@lifesciencelogic.com

 

About Life Science Logic:

Life Science Logic is a commercial strategy consultancy serving small life science and healthcare companies. We help founders and operators build go-to-market strategies, competitive intelligence, and commercial plans with the clarity and rigor that early-stage companies deserve.

Visit https://lifesciencelogic.com/ or reach us at Eric@lifesciencelogic.com.

Disclaimer: The information provided in this podcast is for educational and informational purposes only and does not constitute legal, financial, or regulatory advice. Always consult with qualified professionals regarding your specific situation.

 

 

The Tech Mandate - AI, Telehealth, Cybersecurity, and the Rural Implementation Gap21 sept. 202600:23:20

What

Technology, telehealth, AI, and cybersecurity are one of Texas's core, funded Rural Texas Strong focus areas — not a side track.

Why It Matters

Texas holds the largest first-year RHTP award in the country ($281.3M FY2026, ~$1.4B over five years), and this focus area sits inside three of its six initiatives.

The Catch

AI/telehealth and patient-tech dollars flow through cooperatives (CINs, ACOs), not individual hospitals; cybersecurity is a compliance floor; EHR replacement is capped at 5% of funds.

So What

Organizations that solve the network problem and the staffing/connectivity problem first are the ones positioned to actually use this money.

Resources

Full source list — for internal reference, fact-checking, and listener transparency if published.

  1. CMS — Rural Health Transformation (RHT) Program Overview cms.gov/initiatives/rural-health-transformation-rht-program/overview Used for: Program structure, $50B/5-year funding, statutory allocation formula, national priority areas.
  2. CMS Newsroom — "CMS Announces $50 Billion in Awards to Strengthen Rural Health in All 50 States" cms.gov/newsroom/press-releases/cms-announces-50-billion-awards-strengthen-rural-health-all-50-states Used for: National technology framing, AI scribe/clinical workflow tool references.
  3. Bipartisan Policy Center — "Advancing Technology Innovation through the Rural Health Transformation Program" bipartisanpolicy.org/explainer/advancing-technology-innovation-through-the-rural-health-transformation-program Used for: Four national technology pillars, state award range, 5% EHR-replacement cap, 4% data-infrastructure scoring detail, Indiana/Missouri/New Mexico/Oklahoma EHR examples, Maine/Utah cybersecurity examples.
  4. Texas HHSC Provider Finance Department — Rural Health Transformation Program ("Rural Texas Strong") pfd.hhs.texas.gov/rural-health-transformation-program Used for: Official Texas initiative names, eligibility language for Initiatives 2 and 3 (CIN/ACO/cooperative requirement), procurement process.
  5. Government Market News — "Texas unveils $1.4B rural healthcare transformation plan" govmarketnews.com/texas-unveils-1-4b-rural-healthcare-transformation-plan *Used for: Texas's $281.3M FY2026 award figure and ~$1.4B five-year total.
  6. KFF Health News — "States Race To Launch Rural Health Transformation Plans" kffhealthnews.org/rural-health/rural-health-transformation-state-distribution-technical-scores-variation-deadlines Used for: Confirmation that Texas received the largest first-year state allocation; state-level rollout context.
  7. Texas DSHS — "Update on Rural Health Transformation Program" (PHFPC briefing, Feb. 11–12, 2026) dshs.texas.gov (PHFPC committee documents) Used for: Initiative 2 (Rural Texas Patients in the Driver's Seat) and Initiative 3 (Lone Star Advanced AI and Telehealth) eligibility and scope detail, including the ambient-listening/AI documentation language.
  8. REDi Health — "Texas Rural Health Transformation Program Update" redihealth.com/texas-rural-health-transformation-program Used for: Naming and one-line scope for Texas's six Rural Texas Strong initiatives, including the cybersecurity/infrastructure initiative.
  9. TAP Telehealth — "RHTP Grants for Telehealth: State-by-State" taptelehealth.com/rhtp-grants-telehealth-state-by-state Used for: Cross-check on Texas award figures and Initiative 3 naming.
  10. University of Arizona Telemedicine Program — "Telehealth Innovations in Rural Health" (AZ, CO, NM, NV) telemedicine.arizona.edu/blog/telehealth-innovations-rural-health-how-az-co-nm-and-nv-are-transforming-access-through-cms Used for: Colorado's $255.5M telehealth/technology integration initiative, used as a national comparison point.
  11. EY — "Building a Minimum Viable Digital Foundation for Rural Health" ey.com/en_us/insights/government-public-sector/building-a-minimum-viable-digital-foundation-for-rural-health Used for: Framing of telehealth/interoperability/cybersecurity as baseline infrastructure rather than optional innovation.

 

If you'd like help with your RHTP strategy...shoot me an email: eric@lifesciencelogic.com

 

About Life Science Logic:

Life Science Logic is a commercial strategy consultancy serving small life science and healthcare companies. We help founders and operators build go-to-market strategies, competitive intelligence, and commercial plans with the clarity and rigor that early-stage companies deserve.

Visit https://lifesciencelogic.com/ or reach us at Eric@lifesciencelogic.com.

Disclaimer: The information provided in this podcast is for educational and informational purposes only and does not constitute legal, financial, or regulatory advice. Always consult with qualified professionals regarding your specific situation.

 

 

Rural Texas Strong: Workforce Recruitment, Training, and Retention…Why This Matters14 sept. 202600:18:25

Texas landed the largest single state award in the $50 billion Rural Health Transformation Program - $281.3 million in year one, on the way to $1.4 billion over five years. A major piece of that money, Rural Texas Strong's Initiative Four, is earmarked for rural workforce recruitment and retention. In this episode, Eric Marr breaks down what the workforce funding actually requires - the five-year service commitment, the reporting and FTE obligations, the competitive application process - where rural hospitals, RHCs, and FQHCs are most likely to get tripped up, and how to build a workforce application and plan that's positioned to win and to hold up over the life of the grant.

In this episode:

  • Why Texas's $1.4B Rural Texas Strong award is the biggest test case in the national RHTP rollout
  • What Initiative Four ("The Next Generation of the Small Town Doctor and Team") actually funds
  • The five-year clinical service commitment — and why rural workforce experts are already flagging it as a problem
  • The reporting, data, and FTE requirements hiding inside workforce funding
  • Why generic staffing applications lose to applications mapped directly to the initiative's specific levers
  • The October 2032 deadline and why "use it or lose it" should shape your timeline now
  • How competitive intelligence sharpens an RFA response before you submit

Who this episode is for: Rural hospital district leaders, RHC and FQHC administrators, EMS leadership, and workforce/HR leads in Texas rural health organizations evaluating or preparing an RHTP workforce application.

Resources -

 

About Life Science Logic:

Life Science Logic is a commercial strategy consultancy serving small life science and healthcare companies. We help founders and operators build go-to-market strategies, competitive intelligence, and commercial plans with the clarity and rigor that early-stage companies deserve.

Visit https://lifesciencelogic.com/ or reach us at Eric@lifesciencelogic.com.

Disclaimer: The information provided in this podcast is for educational and informational purposes only and does not constitute legal, financial, or regulatory advice. Always consult with qualified professionals regarding your specific situation.

 

 

 

Healthcare Logic for Growth  ·  Life Science Logic  ·  Eric@lifesciencelogic.com  ·  © 2026 Life Science Logic

Rural Care Roundup - Policy, Pressure, and Proof It Can Work07 sept. 202600:19:49

A look at what's actually happening in the rural care market this month — why September 2026 is a hinge point for RHTP funding, what the rise of private equity ownership means for rural hospital boards, and three real turnaround stories (Grande Ronde Hospital, an RSM-led revenue cycle turnaround, and Bingham Memorial Hospital) that show a path forward without waiting on new federal money.

In this episode:

  • Why CMS's first RHTP program review (Sept 2026) matters even though the money already landed
  • The broadband/connectivity gap complicating telehealth-heavy state RHT plans
  • Why states need a named "payer of record" for when RHT funding tapers
  • What a 2026 Annals of Surgery study found about private equity–acquired rural hospitals
  • How Grande Ronde Hospital (rural Oregon) is projected to move from 1.9% to 9% operating EBITDA margin
  • How one rural hospital avoided closure through disciplined revenue cycle work (RSM case study)
  • How Bingham Memorial Hospital (Blackfoot, ID) turned a referral leakage fix into funding for an MRI and surgical robotics

 

Sources & further reading:

 

Upcoming events referenced:

  • NRHA Rural Health Clinic Conference — Sept 15–16, 2026, Kansas City, MO
  • NRHA Critical Access Hospital Conference — Sept 16–18, 2026, Kansas City, MO

 

 

About Life Science Logic:

Life Science Logic is a commercial strategy consultancy serving small life science and healthcare companies. We help founders and operators build go-to-market strategies, competitive intelligence, and commercial plans with the clarity and rigor that early-stage companies deserve.

Visit https://lifesciencelogic.com/ or reach us at Eric@lifesciencelogic.com.

Disclaimer: The information provided in this podcast is for educational and informational purposes only and does not constitute legal, financial, or regulatory advice. Always consult with qualified professionals regarding your specific situation.

 

 

 

Healthcare Logic for Growth  ·  Life Science Logic  ·  Eric@lifesciencelogic.com  ·  © 2026 Life Science Logic

Rural Texas Strong: The Six Required Initiative Areas31 août 202600:21:44

Rural Texas Strong: The Six Required Initiative Areas

The six initiative areas recapped:

  • Make Rural Texans Healthy Again – Prevention and chronic disease grants to rural hospital districts.
  • Rural Texas Patients in the Driver's Seat – Patient portals and health information exchange, procured through networks.
  • Lone Star Advanced AI and Telehealth – Telehealth, remote monitoring, and predictive tools to close specialist gaps.
  • The Next Generation of the Small Town Doctor and Team – Workforce recruitment and retention, including training and scholarships.
  • Unified Care Infrastructure and Rural Cyber Protection – Shared tech and cybersecurity through DIR contracts.
  • Infrastructure and Capital Investments for Rural Texas – Equipment and facility upgrades, with strict limits on new construction.

References & Resources

  • HHSC: “HHSC to Host Rural Texas Strong Public Forum,” hhs.texas.gov, Aug. 2026
  • HHSC / PFD: Rural Health Transformation Program overview, pfd.hhs.texas.gov/rural-health-transformation-program
  • HHSC: “Rural Texas Strong: Supporting Health and Wellness” fact sheet, pfd.hhs.texas.gov
  • Gov. Abbott's Office: “Governor Abbott, HHSC Submit Application for Rural Health Transformation Program,” gov.texas.gov
  • Texas Hospital Association: “With Large Federal Rural Health Award, Promising Possibilities Abound for Texas,” tha.org
  • The Texan: “Rural Texas Strong: Here's a Look at Developments in the State's Rural Healthcare,” thetexan.news
  • REDi Health: “Texas Rural Health Transformation Program Update,” redihealth.com
  • Texas Association of Counties: “Rural Texas Strong - Initiative 6,” county.org

 

 

About Life Science Logic:

Life Science Logic is a commercial strategy consultancy serving small life science and healthcare companies. We help founders and operators build go-to-market strategies, competitive intelligence, and commercial plans with the clarity and rigor that early-stage companies deserve.

Visit https://lifesciencelogic.com/ or reach us at Eric@lifesciencelogic.com.

Disclaimer: The information provided in this podcast is for educational and informational purposes only and does not constitute legal, financial, or regulatory advice. Always consult with qualified professionals regarding your specific situation.

 

 

 

Healthcare Logic for Growth  ·  Life Science Logic  ·  Eric@lifesciencelogic.com  ·  © 2026 Life Science Logic

The Rural Care Front Door…Why Access is A Key Factor for Texas’ RHTP24 août 202600:24:51

Texas’ Rural Health Transformation Program creates a meaningful opportunity to strengthen access, prevention, workforce capacity, technology, telehealth, cybersecurity, and rural clinical infrastructure.

In this episode, we explore why FQHCs and RHCs should be viewed as the rural care front door. These organizations often provide the first point of contact for patients, support chronic-disease management, deliver preventive services, build trust, and connect patients to hospitals, specialists, behavioral-health providers, and community resources.

Texas has received more than $1.4 billion over five years through the Rural Health Transformation Program, including approximately $281.3 million in first-year funding.

 

Key Takeaways

  • FQHCs and RHCs are different, but both are essential to rural healthcare access.
  • FQHCs provide a community-centered safety-net model and serve patients regardless of ability to pay.
  • RHCs are often a local primary-care access point and can be a critical partner for rural hospitals and telehealth networks.
  • Texas’ Rural Texas Strong strategy includes prevention, patient technology, AI and telehealth, workforce development, cybersecurity, infrastructure, and capital investment.
  • Technology must be supported by workflow design, patient engagement, clinical ownership, staff training, and a sustainable financial model.
  • Strong regional partnerships can create better patient pathways and more sustainable rural-care models.

 

Resources

  • Centers for Medicare & Medicaid Services, Rural Health Transformation Program awards and program overview.
  • Office of the Texas Governor, Rural Texas Strong funding announcement and program priorities.
  • Office of the Texas Governor and Texas HHSC, Rural Health Transformation Program application announcement.
  • Rural Health Information Hub, comparison of Federally Qualified Health Centers and Rural Health Clinics.
  • Health Resources and Services Administration, Rural Health Clinic policy and payment overview.
  • Texas Rural Health Transformation Program overview and six initiative areas.

About Life Science Logic:

Life Science Logic is a commercial strategy consultancy serving small life science and healthcare companies. We help founders and operators build go-to-market strategies, competitive intelligence, and commercial plans with the clarity and rigor that early-stage companies deserve.

Visit https://lifesciencelogic.com/ or reach us at Eric@lifesciencelogic.com.

Disclaimer: The information provided in this podcast is for educational and informational purposes only and does not constitute legal, financial, or regulatory advice. Always consult with qualified professionals regarding your specific situation.

 

 

Healthcare Logic for Growth  ·  Life Science Logic  ·  Eric@lifesciencelogic.com  ·  © 2026 Life Science Logic

RHTP Money vs. Rural Hospital Reality: Why the Math Is Still Questionable.17 août 202600:32:36

Episode Takeaways

  • RHTP is meaningful transformation funding, but it does not fully offset the financial losses, reimbursement pressures, debt, and closure risks facing many rural hospitals.
  • Texas is expected to receive about 281 million dollars annually from RHTP, but its large rural population means the first-year allocation is approximately 66 dollars per rural resident.
  • Rural hospitals should create a prioritized RHTP portfolio based on financial impact, operational feasibility, community need, and long-term sustainability.
  • Vendors should lead with hospital-specific challenges, create RHTP-aligned project designs, offer right-sized models, and clearly explain long-term costs.
  • The best RHTP projects will be measurable, sustainable, and designed to improve the hospital’s ability to serve its community after grant funding ends.

 

Resources Used for This Episode

  • Centers for Medicare & Medicaid Services, Rural Health Transformation Program Overview.
  • Texas Health and Human Services Commission, Provider Finance Department, Rural Health Transformation Program.
  • KFF, First-Year Rural Health Fund Awards Range From Less Than $100 Per Rural Resident in Ten States to More Than $500 in Eight.
  • KFF, analysis of the Rural Health Transformation Fund and Medicaid reductions affecting rural communities.
  • Texas HHS, Rural Hospital Services Strategic Plan Progress Report.
  • APM Research Lab, Rural Health and Hospitals: A Focus on Texas.
  • Rural hospital financial distress and closure research from NIH/PMC and rural health research sources.

About Life Science Logic:

Life Science Logic is a commercial strategy consultancy serving small life science and healthcare companies. We help founders and operators build go-to-market strategies, competitive intelligence, and commercial plans with the clarity and rigor that early-stage companies deserve.

Visit https://lifesciencelogic.com/ or reach us at Eric@lifesciencelogic.com.

Disclaimer: The information provided in this podcast is for educational and informational purposes only and does not constitute legal, financial, or regulatory advice. Always consult with qualified professionals regarding your specific situation.

 

 

 

Healthcare Logic for Growth  ·  Life Science Logic  ·  Eric@lifesciencelogic.com  ·  © 2026 Life Science Logic

RHTP in Texas: Inside the State with the Most Rural Hospitals on the Brink.10 août 202600:18:10

In this episode we cover: Texas has more at-risk rural hospitals than any other state in the country — and the $50 billion Rural Health Transformation Program just arrived to try to change that. We break down what Rural Texas Strong actually funds, and why the math doesn't yet match the scale of the crisis.

 

Key Topics:

01 Texas has the most at-risk rural hospitals (50) of any U.S. state

02 What the Rural Health Transformation Program (RHTP) is and how Rural Texas Strong is structured

03 Why 281 million dollars a year doesn't match the scale of the underlying crisis

04 The gap between "announced" funding and funding that's actually reaching hospitals

 

Go Forward Strategy — 5 Actions:

01 Get your own Texas exposure number this week

02 Bookmark the Rural Texas Strong initiative list, not just the headline

03 Separate "announced" from "available"

04 Watch your customers' payer mix, not just the RHTP headline

05 Start following this series as a system, not a one-off

 

Next Episode: The RHTP Math Problem: Why $281 Million a Year Won't Fix Texas Rural Hospitals' Margins (Episode 2 of the RHTP Series)

About Life Science Logic:

Life Science Logic is a commercial strategy consultancy serving small life science and healthcare companies. We help founders and operators build go-to-market strategies, competitive intelligence, and commercial plans with the clarity and rigor that early-stage companies deserve.

Visit https://lifesciencelogic.com/ or reach us at Eric@lifesciencelogic.com.

Disclaimer: The information provided in this podcast is for educational and informational purposes only and does not constitute legal, financial, or regulatory advice. Always consult with qualified professionals regarding your specific situation.

 

 

 

Healthcare Logic for Growth  ·  Life Science Logic  ·  Eric@lifesciencelogic.com  ·  © 2026 Life Science Logic

Reimbursement - The Hidden Roadblock03 août 202600:21:25

Too many healthcare companies build the product before mapping the reimbursement pathway. And that mismatch - between clinical value and commercial reality - is what stalls otherwise good businesses. The market is only getting less forgiving of that gap. The fix requires discipline: map the pathway, identify the real buyer, build evidence for that buyer specifically, and sequence your commercialization plan around the path to payment - not just the path to launch.

Resources & Data Sources:

  • American Medical Association, "AMA releases CPT 2026 code set" — overview of the 418 total CPT changes, including 288 new codes and new digital health / AI service categories (ama-assn.org).
  • American Medical Association, "The CPT code process" and "CPT code change application FAQs" — official Editorial Panel process, timelines, and reconsideration procedures (ama-assn.org).
  • Courtier Advisory, "Inside the AMA CPT Process: Lessons for MedTech Founders" — founder-side account of multi-year CPT application timelines and evidence-building requirements (coustieradvisory.com).
  • Rock Health, "H1 2026 funding and market overview: Durable roots, shifting routes" and "2025 year-end digital health funding overview" — venture funding concentration data and CMS value-based/outcomes payment model context (rockhealth.com).
  • Rock Health, "Healthcare innovation at the turn of 2026" — employer benefit cost trends and the rise of ICHRAs as a non-traditional benefits channel (rockhealth.com).
  • Life Science Logic internal research and the LSL Intelligence Engine — proprietary market mapping and reimbursement landscape analysis.

 

About Life Science Logic:

Life Science Logic is a commercial strategy consultancy serving small life science and healthcare companies. We help founders and operators build go-to-market strategies, competitive intelligence, and commercial plans with the clarity and rigor that early-stage companies deserve.

Visit https://lifesciencelogic.com/ or reach us at Eric@lifesciencelogic.com.

Disclaimer: The information provided in this podcast is for educational and informational purposes only and does not constitute legal, financial, or regulatory advice. Always consult with qualified professionals regarding your specific situation.

 

 

 

Healthcare Logic for Growth  ·  Life Science Logic  ·  Eric@lifesciencelogic.com  ·  © 2026 Life Science Logic

The Digital Health Dichotomy - Who Gets Funded and Who Doesn’t27 juil. 202600:19:41

In Q1 2026, nearly 60% of digital health investment went to just 12 mega-deals of $100 million or more. This episode breaks down what this funding concentration means for startups and smaller healthcare companies, and provides a practical go-forward strategy for navigating the new reality.

Key Topics Covered:

  • The mega-deal phenomenon and what's driving it
  • Why mid-tier and early-stage companies are getting squeezed out
  • Real-world impact on startups and smaller healthcare companies
  • Strategic responses for founders and operators
  • How Life Science Logic helps companies navigate these challenges

Resources & Data Sources:

  • Rock Health Q1 2026 Digital Health Funding Report
  • Galen Growth U.S. Digital Health Funding Q1 2026 Analysis
  • Healthcare Dive coverage of H1 2026 funding trends
  • Life Science Logic Intelligence Engine

About Life Science Logic:

Life Science Logic is a commercial strategy consultancy serving small life science and healthcare companies. We help founders and operators build go-to-market strategies, competitive intelligence, and commercial plans with the clarity and rigor that early-stage companies deserve.

Visit https://lifesciencelogic.com/ or reach us at Eric@lifesciencelogic.com.

Disclaimer: The information provided in this podcast is for educational and informational purposes only and does not constitute legal, financial, or regulatory advice. Always consult with qualified professionals regarding your specific situation.

 

 

 

Healthcare Logic for Growth  ·  Life Science Logic  ·  Eric@lifesciencelogic.com  ·  © 2026 Life Science Logic

For Digital Health Firms - Providing Clinical Value, Not Just Engagement Metrics Is Critical20 juil. 202600:18:06

In this episode of Healthcare Logic for Growth, we talked about why digital health companies must prove clinical value, not just engagement. We covered why activity metrics like downloads and retention are no longer enough on their own, why investors and health systems want stronger evidence, and why startups often struggle to generate proof within limited runway.

We also walked through a practical go-forward strategy for defining the outcome you need to prove, matching evidence to the buyer, limiting metrics, and connecting proof to adoption. Finally, we briefly discussed how Life Science Logic helps companies think through the path from product to proof to commercialization through GTM Sprint, GTM Crossroads, CIB, Advisory Services, and Commercialization Services.

Resources:

We looked at a PubMed article, “Applying Evidence-Based Medicine Standards to Digital Tools,” which argues that digital health tools should meet evidence expectations similar to other clinical interventions. pubmed.ncbi.nlm.nih

We also reviewed the Lancet Digital Health article, “Advancing digital health applications: priorities for innovation in real-world evidence generation,” which discusses the importance of real-world evidence in digital medicine. thelancet

Another important source was the npj Digital Medicine article, “Digital therapeutics from bench to bedside,” which covers the role of real-world evidence, commercialization, and barriers to broader adoption. nature

We also referenced a digital health commercialization framework from MIT, which helps support the broader strategy discussion.dspace.mit+1

And we looked at a recent Healthcare Logic for Growth episode that focused on what healthcare startups need to do to win, including proving outcomes, fitting workflow, and building the payment model early. Published on Spotify, Apple Podcasts, iHeart Rdio and YT

And lastly, we used the Life Science Logic Intelligence Engine, our internal life sciences AI, to help synthesize the evidence and sharpen the strategic takeaways for this episode.

Have a question or topic you'd like us to cover? Reach out to us at eric@lifesciencelogic.com

About Life Science Logic:

Life Science Logic is a commercial strategy consultancy serving small life science and healthcare companies. We help founders and operators build go-to-market strategies, competitive intelligence, and commercial plans with the clarity and rigor that early-stage companies deserve.

Visit https://lifesciencelogic.com/ or reach us at Eric@lifesciencelogic.com.

Disclaimer: The information provided in this podcast is for educational and informational purposes only and does not constitute legal, financial, or regulatory advice. Always consult with qualified professionals regarding your specific situation. 

 

Healthcare Logic for Growth  ·  Life Science Logic  ·  Eric@lifesciencelogic.com  ·  © 2026 Life Science Logic

Home Is the New Site of Care: Why Home-Based Growth Depends on Design Not Just Demand13 juil. 202600:14:45

Why growing in home health care requires a new staffing, reimbursement, and service design model—and what small agencies need to check before accepting new referrals.

Key Topics:

  1. The myth that home health care is just cheaper facility care
  2. Drive-time-adjusted staffing ratios
  3. Setting-specific reimbursement realities
  4. Service design for the home environment
  5. Evaluating referrals by payer mix and margin

 

Go Forward Strategy - 5 Actions:

  1. Build a Drive-Time-Adjusted Staffing Model This Week
  2. Pull the Reimbursement Rate Before You Expand
  3. Map Your Referral Sources by Payer Mix, Not Just Volume
  4. Audit One Service Line for Home-Environment Risk
  5. Say No to One Referral Relationship Until the Math Works

 

Resource Mentioned:

Building A Potential Tool for Home-Based Care Margin Mapping (based on 10-15 followers or subscriptions)

 

Follow & Subscribe:

Don't miss an episode! Subscribe to Healthcare Logic for Growth on wherever you get your podcasts.

Apple Podcasts:

https://podcasts.apple.com/us/podcast/healthcare-logic-for-growth/id1890160182

Spotify:

https://open.spotify.com/show/1YSwyajbIWDkVWwrIPM1j3

YouTube:

https://www.youtube.com/@HealthcareLogicforGrowth

 

Have a question or topic you'd like us to cover? Reach out to us at eric@lifesciencelogic.com

About Life Science Logic:

Life Science Logic is a commercial strategy consultancy serving small life science and healthcare companies. We help founders and operators build go-to-market strategies, competitive intelligence, and commercial plans with the clarity and rigor that early-stage companies deserve.

Visit https://lifesciencelogic.com/ or reach us at Eric@lifesciencelogic.com.

Disclaimer: The information provided in this podcast is for educational and informational purposes only and does not constitute legal, financial, or regulatory advice. Always consult with qualified professionals regarding your specific situation.

 

 

 

Healthcare Logic for Growth  ·  Life Science Logic  ·  Eric@lifesciencelogic.com  ·  © 2026 Life Science Logic

What we've learned in the 1st 6 months of 202606 juil. 202600:22:13

In this episode of Healthcare Logic for Growth, we break down the pivotal trends from the first half of 2026 that every small and start-up healthcare company needs to know. We explore the good news (rebounding venture funding, FDA fast-track vouchers, and digital health pilot programs), the bad news (FDA staffing shortages, drug pricing uncertainty, and OMB grant threats), and the "data trap" catch-22 that is stifling early-stage biotechs. We share 10 actionable steps to help you navigate the next six months with confidence.

Sources Referenced in This Episode:

- HSBC Innovation Banking – US Healthcare Venture Investment Report: Provided the $60 billion funding data and the trend of investors demanding later-stage traction from seed-stage companies.

- PharmaVoice – Life Sciences 2026 Outlook & FDA Staffing Analysis: Sourced the quotes on FDA staffing challenges post-DOGE and the uncertainty surrounding political appointees at the agency.

- FDA Official Guidance & Pilot Programs (2026):

- Commissioner’s National Priority Voucher Program (Fast-track review).

- TEMPO Pilot Program (Enforcement discretion for digital health technologies).

- Revised Guidance on Low-Risk Wellness & Clinical Decision Support Software.

- CMS – ACCESS Model Demonstration: Source for the outcomes-based reimbursement model for digital health and medical devices.

- Federal Register / OMB – Proposed Rule on Grant Cancellations (May 2026): Source for the non-scientific criteria clause affecting SBIR and NIH grants.

- White House Executive Orders – Most Favored Nation Pricing & IRA Implementation Updates: Source for drug pricing pressures.

- Congressional Bills – Biotech Workforce Development & Biosecure Act: Source for talent pipeline initiatives and supply chain manufacturing restrictions.

- Industry Venture Capital Panel Discussions (Q1/Q2 2026) – various: Sourced the "ship at 92%" mentality and the commercial leadership cautionary tale.

Follow & Subscribe:

Don't miss an episode! Subscribe to Healthcare Logic for Growth on wherever you get your podcasts.

Apple Podcasts:

https://podcasts.apple.com/us/podcast/healthcare-logic-for-growth/id1890160182

Spotify:

https://open.spotify.com/show/1YSwyajbIWDkVWwrIPM1j3

YouTube:

https://www.youtube.com/@HealthcareLogicforGrowth

 

Have a question or topic you'd like us to cover? Reach out to us at eric@lifesciencelogic.com

About Life Science Logic:

Life Science Logic is a commercial strategy consultancy serving small life science and healthcare companies. We help founders and operators build go-to-market strategies, competitive intelligence, and commercial plans with the clarity and rigor that early-stage companies deserve.

Visit https://lifesciencelogic.com/ or reach us at Eric@lifesciencelogic.com.

Disclaimer: The information provided in this podcast is for educational and informational purposes only and does not constitute legal, financial, or regulatory advice. Always consult with qualified professionals regarding your specific situation.

 

 

 

Healthcare Logic for Growth  ·  Life Science Logic  ·  Eric@lifesciencelogic.com  ·  © 2026 Life Science Logic

What Healthcare Startups Need to Do to Win - and Why So Many Fail29 juin 202600:23:50

In this episode of Healthcare Logic for Growth, we break down what healthcare startups need to do to succeed - and why so many fail. We cover the five biggest success factors, including solving a real problem, proving outcomes, building the payment model early, fitting into clinical workflows, and scaling with trust. We also look at five common failure patterns, including weak validation, no reimbursement path, long sales cycles, poor workflow fit, and trust breakdowns.

We use real-world examples from Omada Health, Oshi Health, Zocdoc, Theranos, and Babylon Health to show what success and failure look like in practice. If you’re building, investing in, or marketing to healthcare startups, this episode is a practical guide to what actually matters. Key Topics - Why healthcare startups are different from consumer tech. - The five things a healthcare startup needs to do to succeed. - The five most common reasons healthcare startups fail. - Lessons from real companies with public-facing data. - Questions founders should ask to stay on track. - A go-forward strategy for building a durable healthcare company.

Sources Referenced in This Episode:

- AMA case study on Omada Health, highlighting evidence-based care, data-powered coaching, connected devices, and care coordination.

- Omada public platform information on outcomes and care delivery.

- AMA and related public materials on Oshi Health, including multidisciplinary GI care, outcomes, and cost savings.

- Zocdoc’s public milestone update on profitability, cash flow, provider growth, and business model improvements.

- STAT’s analysis of why healthcare startups fail, especially around reimbursement, pricing, and operational complexity.

- Public materials on Theranos’s failures and regulatory issues.

- Public reporting and analysis on Babylon Health’s collapse and reimbursement challenges.

About Life Science Logic:

Life Science Logic is a commercial strategy consultancy serving small life science and healthcare companies. We help founders and operators build go-to-market strategies, competitive intelligence, and commercial plans with the clarity and rigor that early-stage companies deserve.

Visit https://lifesciencelogic.com/ or reach us at Eric@lifesciencelogic.com.

 

Healthcare Logic for Growth  ·  Life Science Logic  ·  Eric@lifesciencelogic.com  ·  © 2026 Life Science Logic

Priced to Win - How Small Life Science Companies Turn the MFN Drug Pricing Disruption Into a Commercial Advantage22 juin 202600:28:07

The MFN drug pricing framework - what began as voluntary agreements with sixteen of the largest pharmaceutical companies - is now moving toward mandatory rules that will reach smaller biotechs and pharma companies. At the same time, a 100% pharmaceutical tariff takes effect September 29th for smaller manufacturers, with a lower 20% rate available only to companies that have engaged the MFN framework and filed domestic manufacturing plans.

BIO International opens at the same time of this published episode, June 22nd. So, in this episode, we flip the script: instead of treating MFN as a threat, we show small life science companies how to turn it into a commercial advantage - with five specific actions you can take starting this week.

 

Sources Referenced in This Episode:

Skadden Arps — "MFN Drug Pricing and Impact on International Life Sciences Licensing Deals" — June 1, 2026

BioTech Briefings / Gibson Dunn — "MFN Drug Pricing in 2026: Voluntary Deals Are Giving Way to Mandatory Rules" — March 2026

Clinical Leader — "U.S. Pharma Tariffs and MFN Become Law After April 2 Update" — April 2026

AJMC — "MFN Drug Pricing Proposal Raises Questions Around Access, Innovation, and Commercial Coverage" — June 2026

BioSpace — "Despite MFN Deals, Drug Pricing Will Dog Pharma Into 2026"

PharmExec — "What the Most Favored Nation Executive Order Means to Pharma Brands and Future Implications" — April 2026

BIO International Convention 2026 — San Diego, June 22–25, 2026 — convention.bio.org

White House Council of Economic Advisers — "Savings from Most-Favored-Nation Drug Pricing Policy" — May 2026

About Life Science Logic:

Life Science Logic is a commercial strategy consultancy serving small life science and healthcare companies. We help founders and operators build go-to-market strategies, competitive intelligence, and commercial plans with the clarity and rigor that early-stage companies deserve.

Visit https://lifesciencelogic.com/ or reach us at Eric@lifesciencelogic.com.

 

Healthcare Logic for Growth  ·  Life Science Logic  ·  Eric@lifesciencelogic.com  ·  © 2026 Life Science Logic

From Innovation to Revenue: How Healthcare Startups Turn a Great Product Into a Real Business15 juin 202600:28:27

Healthcare is full of great products that never became great businesses. In this first episode of the Healthcare Startup Revenue Series, we break down 4 of the structural barriers that accelerate performance:

  • Buyer vs. user separation
  • Long purchasing cycles
  • The evidence requirement
  • Economic model misalignment

Whether you’re still in your first year of commercial activity or stuck at early customers and unable to scale, this episode gives you a foundation to consider.

Sources Referenced:

 

About Life Science Logic:

Life Science Logic helps hospitals, HHAs, healthcare associations, small life science and healthcare companies go to market smarter, not more expensively. We combine commercial strategy, competitive intelligence, and planning with a disciplined, cost-conscious approach - delivering the rigor of a top-tier consultancy without the expanded overhead. The result? Our clients cut unnecessary spending, improve commercial efficiency, and give better performance earlier.

Ready to spend less and perform better? Learn more at https://lifesciencelogic.com/ or reach us at Eric@lifesciencelogic.com.

 

Healthcare Logic for Growth  ·  Life Science Logic  ·  Eric@lifesciencelogic.com  ·  © 2026 Life Science Logic

CMS Just Changed the Playbook for GLP-1...Consider the Following08 juin 202600:28:05

On May 1, 2026, the CMS BALANCE Model went live - opening the door for Medicaid agencies to begin enrolling in a new federal framework that expands GLP-1 coverage for obesity and metabolic disease. The Medicare GLP-1 Bridge follows on July 1st, giving Medicare Part D beneficiaries access to these drugs at $50 per month. Most of the conversation has focused on Novo Nordisk and Eli Lilly. This episode is for everyone else. We break down what BALANCE actually does, what the commercial ecosystem around it looks like for small pharma, biotech, digital health companies, home health agencies, and hospitals - and five specific actions you should be taking right now.

 

Sources Referenced in This Episode:

  • KFF - 'What to Know About the BALANCE Model for GLP-1s in Medicare and Medicaid and the Medicare GLP-1 Bridge' - Updated May 11, 2026
  • CMS Innovation Center - BALANCE Model Official Page and Implementation Timeline - cms.gov
  • CMS - 'Innovation Insight: Affordability of GLP-1s Takes Next Step with BALANCE Model RFAs' - March 9, 2026
  • Eli Lilly - Updated Statement on CMMI BALANCE Model and Medicare GLP-1 Bridge - March 2026
  • Fierce Healthcare - 'CMS Launching Payment Model to Boost Access to GLP-1s in Medicaid, Part D' - December 2025
  • IQVIA - 'Outlook for Obesity in 2026: From Consolidation to Acceleration' - January 2026
  • MMM Online - '2026 Is the Year GLP-1s Grow Up' - February 2026
  • AJMC - 'MFN Drug Pricing Proposal Raises Questions Around Access, Innovation, and Commercial Coverage' - May 22, 2026

 

About Life Science Logic:

Life Science Logic is a commercial strategy consultancy serving small life science, healthcare companies, and healthcare investors. We help founders and operators navigate go-to-market strategy, competitive intelligence, and commercial planning with the clarity and rigor that early-stage companies deserve and need. Learn more at https://lifesciencelogic.com/ or reach me at Eric@lifesciencelogic.com.

Healthcare Logic for Growth  ·  Life Science Logic  ·  Eric@lifesciencelogic.com  ·  © 2026 Life Science Logic

The Pilot Era Is Over - AI in Healthcare Has Crossed Into Real ROI, and Small Companies Are Running Out of Time to Catch Up01 juin 202600:40:53

Healthcare is deploying AI tools at more than twice the rate of the broader economy — and for the first time at meaningful scale, the ROI is real and documented. In this episode, we unpack the NVIDIA State of AI in Healthcare 2026 survey and this week's Healthcare IT News report on AI payment alignment to answer the question every small healthcare company is quietly asking: what does the AI inflection point actually mean for my business right now? We cover three real-world scenarios across six audience segments — hospitals, home health agencies, digital health startups, pharma, biotech, and healthcare associations — and close with six specific actions you can take this week.

 

Links:

  • NVIDIA -'State of AI in Healthcare and Life Sciences: 2026 Trends' -February 2026
  • Healthcare IT News - 'Realizing the full value of AI in healthcare will require better alignment between payment models, regulatory expectations and outcomes' -May 21, 2026
  • Healthcare Dive - 'Top Healthcare AI Trends in 2026' -January 2026
  • BCG/BCG X -'How AI Agents and Tech Will Transform Health Care in 2026' - March 2026
  • Wolters Kluwer -'2026 Healthcare AI Trends: Insights from Experts' -December 2025
  • Chief Healthcare Executive -'AI in Health Care: 26 Leaders Offer Predictions for 2026' - January 2026
  • Bipartisan Policy Center - 'FDA Oversight: Understanding the Regulation of Health AI Tools' - March 2026
  • Precedence Research - AI in Healthcare Market Size Forecast - November 2025

About Life Science Logic:

Life Science Logic is a commercial strategy consultancy serving small life science, healthcare companies, and healthcare investors. We help founders and operators navigate go-to-market strategy, competitive intelligence, and commercial planning with the clarity and rigor that early-stage companies deserve and need. Learn more at https://lifesciencelogic.com/ or reach me at Eric@lifesciencelogic.com.

Healthcare Logic for Growth  ·  Life Science Logic  ·  Eric@lifesciencelogic.com  ·  © 2026 Life Science Logic

The Medicaid Clock Is Already Ticking - What Every Small Healthcare Company Needs to Know Right Now25 mai 202600:23:44

On May 1st, 2026, Nebraska became the first state in the country to enforce Medicaid work requirements under the One Big Beautiful Bill Act - the sweeping federal law that includes nearly a trillion dollars in Medicaid cuts over ten years. Montana goes live July 1st. Iowa in December. And 43 states are federally required to follow by January 1st, 2027. In this episode, we break down what this means for small life science and healthcare companies, why the 2027 framing is the wrong planning frame, and five specific steps you should be taking right now to protect your revenue model and your commercial strategy.

Sources Referenced in This Episode:

  • NPR - 'It's Day 1 of Medicaid Work Requirements in Nebraska,' May 1, 2026
  • KFF - 'An Early Look at Policy Decisions as States Get Ready to Implement Work Requirements,' May 2026
  • GoodRx Health - 'New Medicaid Work Requirements (2026): What to Know,' May 2026
  • AJMC - 'Medicaid Work Requirements Set to Leave Millions Without Insurance,' May 2026
  • Becker's Hospital Review - 'Hospitals Brace for New Wave of Federal Cuts,' April 2026
  • Center on Budget and Policy Priorities (CBPP) - 'States Need More Time to Prepare,' April 2026
  • KFF - 'How Might Federal Medicaid Cuts Affect Rural Areas?' September 2025
  • Fierce Healthcare - '2026 Outlook: The Domino Effect of Medicaid Cuts,' March 2026

 

About Life Science Logic:

Life Science Logic is a commercial strategy consultancy serving small life science, healthcare companies, and healthcare investors. We help founders and operators navigate go-to-market strategy, competitive intelligence, and commercial planning with the clarity and rigor that early-stage companies deserve and need. Learn more at https://lifesciencelogic.com/ or reach me at Eric@lifesciencelogic.com.

 

Healthcare Logic for Growth  ·  Life Science Logic  ·  Eric@lifesciencelogic.com  ·  © 2026 Life Science Logic

The FDA Just Changed the Rules on Coverage - What Early-Stage Companies Need to Know.18 mai 202600:14:37

On April 23, 2026, the FDA and CMS announced the RAPID coverage pathway - a new program designed to cut the historically long gap between FDA device authorization and Medicare coverage from a year or more down to as little as two months. For early-stage life science device companies, this changes the commercial math.

In this episode, we break down exactly what RAPID is, who qualifies, what it means for your launch strategy, and five specific steps you should be taking right now.

  1. Determine your eligibility right now. If you have or are pursuing Breakthrough Device designation for a Class II or Class III device with a significant Medicare-age patient population, RAPID may apply to you.
  2. Audit your IDE study design immediately. The RAPID pathway requires that your clinical outcomes be agreed upon by both FDA and CMS in advance. If your current study design was built solely around FDA's evidentiary requirements, you may have a gap.
  3. Request a CMS engagement meeting. CMS has committed to early and frequent engagement with RAPID-eligible device companies during development. That is not a formality - it is a strategic resource built into the pathway.
  4. Update your commercial launch model. If you have been modeling a one-to-two year gap between FDA authorization and Medicare coverage, and RAPID applies to your device, your timeline assumptions are out of date.
  5. Engage the public comment process. When the RAPID proposed procedural notice hits the Federal Register, you will have 60 days to submit comments.

Sources Referenced in This Episode:

  • CMS.gov - RAPID Coverage Pathway Press Release, April 23, 2026
  • FDA.gov - Joint CMS/FDA Announcement, April 23, 2026
  • Foley Hoag LLP - RAPID Pathway Legal Analysis, April 2026
  • Healthcare Dive - 'CMS, FDA unveil speedier Medicare coverage pathway,' April 23, 2026
  • STAT News - 'CMS, FDA propose new, faster coverage for breakthrough devices,' April 23, 2026
  • Arnold & Porter - Regulatory & Reimbursement Analysis, April 2026

 

About Life Science Logic:

Life Science Logic is a commercial strategy consultancy serving small life science, healthcare companies, and healthcare investors. We help founders and operators navigate go-to-market strategy, competitive intelligence, and commercial planning with the clarity and rigor that early-stage companies deserve and need. Learn more at lifesciencelogic.com or reach me at Eric@lifesciencelogic.com.

CONNECT

 

Biotech in 2026: The Capital, Clinical, and Commercial Triple Threat11 mai 202600:13:57

Biotech in 2026 is operating inside a Triple Threat. In this episode, we break down the three forces hitting simultaneously: capital pressure that now demands commercial readiness alongside clinical proof, clinical complexity that has turned trial design into a commercial decision, and commercial infrastructure gaps that show up at the worst possible moment - right when you need them most.

 

If you're leading an early-stage biotech, preparing for a Series B, or building out your first commercial team, this episode gives you an honest picture of the landscape and three clear actions you can take right now.

WHY THIS MATTERS

The playbook that worked three years ago no longer applies. Capital is concentrating at later stages and investors are asking commercial questions earlier. Payers are demanding evidence that gets built into trial design - not bolted on after approval. And the gap between FDA approval and commercial success has not gotten any shorter.

 

What's different in 2026 is that these three pressures are compounding each other. A weak commercial story makes fundraising harder. A misaligned trial design creates payer problems at launch. And a company that hasn't built commercial infrastructure in parallel with clinical development finds itself scrambling when the window opens. This episode is about seeing all three threats clearly - and acting on them now.

WHAT WE COVER

  • The 2026 biotech landscape - what's changed and what hasn't
  • Threat 1: Capital Pressure - why investors now require commercial readiness alongside clinical proof
  • Threat 2: Clinical Complexity - why trial design is now a commercial decision, not just a regulatory one
  • Threat 3: Commercial Readiness - the infrastructure problem that shows up at the worst possible time
  • The Myth/Misconception: 'We'll figure out commercial after approval' - and why that window is now closed
  • How the three threats compound each other - and what that means for your planning horizon

YOUR GO FORWARD STRATEGY — 3 ACTIONS FROM THIS EPISODE

1 - Map your trial endpoints against payer coverage criteria - do this before your next protocol amendment, not after approval

2 - Build your one-page commercial narrative before your next investor meeting - your clinical story needs a commercial chapter

3 - Book one payer conversation this quarter - not to pitch, but to listen and learn what they'll actually need to see

CONNECT

 

Healthcare Logic for Growth  ·  Life Science Logic  ·  Eric@lifesciencelogic.com  ·  © 2026 Life Science Logic

The Honest State of Early-Stage Life Science in 2026: What Every Biotech, Pharma, MedTech, and Digital Health Company Is Really Up Against04 mai 202600:17:02

In this opening episode of the Early-Stage Life Science series, host Eric delivers an honest 30,000-foot assessment of what early-stage life science companies are up against in 2026. Not the headline version. The operational reality.

WHY THIS EPISODE MATTERS

The life sciences landscape looks strong from the outside -  a recovering biotech index, active M&A, and AI transforming drug discovery at a real pace. But underneath those headlines, the environment for early-stage companies has quietly gotten harder.

Capital is concentrating at later stages. The regulatory and reimbursement infrastructure hasn't gotten simpler. NIH funding pullbacks are creating upstream pressure that will shape the pipeline for years. The companies that succeed in this environment are the ones who see it clearly - not the ones running on optimism alone.

This episode gives you that clear view - and a practical starting point for building commercial strategy that holds up under the pressure of 2026.

WHAT WE COVER

  • The 2026 Landscape - Where the macro environment really stands - and why the operational reality for early-stage companies doesn't match the headlines.
  • The Commercial Strategy Gap - Why treating commercial strategy as something that happens after the science is done is one of the most costly mistakes in early-stage life science - and what parallel-track development looks like.
  • Capital Efficiency Under Pressure - How to connect every dollar to a fundable milestone - and why capital discipline has become a commercial strategy in itself.
  • The Payer and Reimbursement Wall - FDA approval doesn’t equal market access. What it takes to build a payer strategy that works - and why you need to start years before launch.
  • Talent and Team Building - Why the talent you need most is the hardest to attract at an early stage - and how the companies winning in 2026 are approaching it proactively.
  • Communication and Visibility - Why a company with strong science and low external presence is leaving relationships and resources on the table - and how to fix it before you need something from the market.

GO FORWARD STRATEGY - 5 ACTIONS YOU CAN TAKE THIS WEEK

01 - Run a Commercial Readiness Check - Pull up your milestone map. Next to each clinical or regulatory milestone, write the commercial question it should be answering. If you can't write one, that's your gap.

02 - Map Capital Needs Against Commercial Milestones - Every dollar should be traceable to a milestone that strengthens your next raise. Line items that don't connect? That's your first efficiency opportunity.

03 - Have the Payer Conversation Earlier Than Feels Comfortable - If you haven't spoken with a payer medical director or pharmacy director about your product and evidence strategy, schedule that meeting this week.

04 - Audit Your Visibility in the Conversations That Matter - Identify the 3–5 conferences or forums where your key stakeholders gather. Is your company present and credible there?

05 - Name Your Biggest Commercial Blind Spot - Of the five challenge areas covered today, which one is your company most exposed to right now? Name it, write it down, and bring it to your next leadership meeting as a strategic priority.

 

CONNECT

Healthcare Logic for Growth · Life Science Logic · Eric@lifesciencelogic.com © 2026 Life Science Logic. All rights reserved.

Welcome to 'Healthcare Logic for Growth.'01 mai 202600:02:20

Actionable Insights and Go-Forward-Strategies for Hospitals, Clinics, Home Health, and Emerging Healthcare Companies

Welcome to Healthcare Logic for Growth, the podcast from Life Science Logic where clinical breakthroughs meet commercial reality, where hospitals near-term challenges are discussed and translate into keeping the doors open, where healthcare leadership and their team can discover a revenue architecture that drives and sustains growth. Hosted by Eric Marr, this show is for the builders - founders, executives, clinicians, and innovators across home health, clinics, pharma, biotech, medtech, digital health, health systems, and rural hospitals. Each week, we break down the logic behind real healthcare growth. Not just the science - but the strategy. We explore go-to-market plays, market intelligence, and practical frameworks for navigating healthcare’s unique complexity. From ideation to clinical application to commercialization and adoption, we share hard-earned lessons from both failures and wins.

CONNECT

.

 

© My Podcast Data · Independent project · Data from Apple & Spotify